# Orlistat/Phentermine Versus Placebo/Phentermine

> **NCT03675191** · NA · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 114 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Orlistat 120Mg Cap
- **DRUG:** Phentermine Pill

## Key facts

- **NCT ID:** NCT03675191
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-16
- **Primary completion:** 2019-07-12
- **Final completion:** 2019-08-12
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675191, "Orlistat/Phentermine Versus Placebo/Phentermine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03675191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*